Dexmedetomidine as an Adjuvant with Ropivacaine in Supraclavicular Brachial Plexus Block in Upper Limb Surgeries: A Case Control Study
Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 11
Abstract
Background and Aims: The aim of this study was to find out the effect of Dexmedetomidine used as an adjuvant with Ropivacaine in Supraclavicular brachial plexus block in upper limb surgeries. Materials and Methods: 80 patients undergoing elective upper limb surgeries under Supraclavicular brachial plexus block and belonging to American society of Anesthesiologists Grade I or II were divided into 2 groups of 40 patients each. Group A (n=40) received 30 ml 0.5% Ropivacaine and 1 ml normal saline and Group D (n=40) received 30 ml 0.5% Ropivacaine and 1 μg/kg of Dexmedetomidine. The primary outcome was evaluated in term of duration of analgesia. Other outcomes which were evaluated included time of onset and duration of sensory and motor blockade, degree of analgesia and sedation, vital parameters during and in immediate postoperative period. Results: Demographic profile and mean duration of surgery was similar in both the groups. Onset of sensory and motor blockade was found to be earlier in Group D than in Group A. The duration of sensory and motor block was statistically significantly prolonged in group D than in group A. Duration of analgesia and degree of sedation was also higher in group D than in group A. The incidence of bradycardia was more in group D than in Group A. Other vital parameters like mean arterial pressure and SPO2 were comparable in both the groups. Conclusion: Addition of dexmedetomidine as an adjuvant to ropivacaine in supraclavicular brachial Plexus block in upper limb surgeries is associated with prolonged postoperative analgesia, better sedation and shortened time for onset of sensory and motor block. It is associated with statistically significant prolonged duration of brachial plexus block in comparison with use of ropivacaine alone. Use of dexmedetomidine is found to be associated with increased incidence of bradycardia.
Authors and Affiliations
Dr Jayant Prakashrao Shinde
Benign, Multicentric, Recurrent and Metastasizing Giant Cell Tumor of Bone: Review of Literature with Role of Immunohistochemistry in Determining Prognosis
Objective: Giant cell tumor (GCT) represents around 4-5% of all primary bone tumors. The purpose of this article is to report this unusual case of benign metastasizing GCT and simultaneously emphasize on the role of immu...
A survey on consequences related to the low conversion of patients from outpatient department to in-patient department at a multispecialty hospital
This study is based on the research conducted at a multispecialty hospital, at Ahmadabad, Gujarat. The study had been undertaken with the primary objective of analyzing the results and reasons due to that patient visitin...
Prevalence of Hyperuricemia and Relation of Serum Uric Acid with Cardiometabolic Risk Factors
Cardiometabolic diseases like metabolic syndrome (Mets), cardiovascular disease (CVD) and type 2 diabetes mellitus have several risk factors in common. Several biochemical markers are in current use as laboratory diagnos...
Comparision of Cleaning Efficiency of Rotary Protaper and Self Adjusting File in Oval Shaped Canals – An In- Vitro Study
Background: Oval shaped canals pose a challenge to endodontists. Self adjusting files have been introduced in the field of endodontics to overcome the deficiencies of rotary protapers in preparing oval canals. Aims and O...
Management of Juvenile Ossifying Fibroma by Aggressive Curettage – A Case Report
Juvenile ossifying fibroma is a benign, but potentially aggressive, fibro osseous tumour of the craniofacial bones1 . The authors describe a case of a juvenile ossifying fibroma of mandible presenting in a 17-year-old gi...